We used these values, in addition to in-vitro-measured PD-L1 and MHC-I expression by tumor cells (Figure 2A) and changes in cellular metabolism (Figure 2B), as inputs to initialize both T cells and tumor cells in the model and ran modeling simulations that mimicked our in vitro killing assay setup. The gene discussed is CD274; the disease is neoplasm.